» Authors » Jens Brondum Frokjaer

Jens Brondum Frokjaer

Explore the profile of Jens Brondum Frokjaer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 132
Citations 1035
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hagn-Meincke R, Frokjaer J, Drewes A, Holmboe C, Krogh K, Nedergaard R, et al.
Pancreatology . 2025 Mar; PMID: 40069033
Background: Chronic pancreatitis (CP) is a fibro-inflammatory disease that damages the pancreas, leading to severe abdominal pain and metabolic complications. Activated macrophages and pancreatic stellate cells drive CP progression, and...
2.
Nordaas I, Trelsgard A, Tjora E, Frokjaer J, Haldorsen I, Olesen S, et al.
Pancreatology . 2024 Nov; 24(8):1244-1251. PMID: 39567271
Objectives: Pancreatic atrophy is commonly observed in end-stage chronic pancreatitis (CP). Diagnostic standards for pancreatic atrophy not well established. The present cross-sectional observation study explored two-point pancreatic size measurements in...
3.
Kufaishi H, Bertoli D, Kornum D, Ranjan A, Norgaard K, Krogh K, et al.
Diabetes Technol Ther . 2024 Oct; 27(1):52-59. PMID: 39446990
Autonomic neuropathy is associated with dysglycemia that is difficult to control. We investigated if transcutaneous vagus nerve stimulation (tVNS) could improve glycemic levels. We randomized 145 individuals with type 1...
4.
Eggertsen C, Larsen R, Duch K, Simonsen M, Christensen C, Warner T, et al.
Int J Obes (Lond) . 2024 Oct; 49(2):269-277. PMID: 39390066
Background: Multidisciplinary lifestyle interventions for children with obesity in Denmark often include recommendations regarding physical activity, but no structured exercise program. We hypothesized that adding high-intensity interval training (HIIT) to...
5.
Mark E, Okdahl T, Kahlke D, Moller Hansen L, Krogh K, Frokjaer J, et al.
Neurogastroenterol Motil . 2024 Oct; 36(12):e14941. PMID: 39375836
Background: Opioids inhibit motility and secretion of the gut and have been used for antidiarrheal treatment for centuries. However, the underlying mechanisms of opium tincture are not evident. Aim: To...
6.
Hagn-Meincke R, Dugic A, Agarwal A, Evans Phillips A, Waage A, Yadav D, et al.
Pancreas . 2024 Sep; 54(1):e1-e10. PMID: 39259852
Objectives: Pain is the foremost complication of chronic pancreatitis (CP), affecting about 70% of patients. However, the pathophysiological understanding and management of CP-related pain are complex, likely as patients have...
7.
Larsen I, Okdahl T, Mark E, Frokjaer J, Drewes A
Basic Clin Pharmacol Toxicol . 2024 Aug; 135(4):475-490. PMID: 39168825
Tramadol is a weak opioid used to treat moderate pain. Stronger opioids inhibit gastrointestinal function, but little is known about the gastrointestinal effects of tramadol. Our aim was to investigate...
8.
Brath M, Kristensen S, Sahakyan M, Mark E, Rasmussen H, Ostergaard L, et al.
Am J Clin Nutr . 2024 Jun; 120(3):696-706. PMID: 38936776
Background: Computed tomography (CT) has an underutilized potential for evaluating body composition in clinical settings. Often conducted with intravenous contrast (IVC), CT scans yield unused body composition data due to...
9.
Knoph C, Cook M, Novovic S, Hansen M, Mortensen M, Nielsen L, et al.
Am J Gastroenterol . 2024 Jun; 119(11):2307-2316. PMID: 38916223
Introduction: Opioids used to manage severe pain in acute pancreatitis (AP) might exacerbate the disease through effects on gastrointestinal and immune functions. Methylnaltrexone, a peripherally acting µ-opioid receptor antagonist, may...
10.
Gjela M, Askeland A, Mellergaard M, Drewes A, Handberg A, Frokjaer J
Scand J Gastroenterol . 2024 Apr; 59(6):742-748. PMID: 38557425
Objectives: Intra-pancreatic fat deposition (IPFD) is suspected to be associated with various medical conditions. This study aimed to assess pancreatic fat content in lean and obese individuals, characterize obese individuals...